Medtronic’s LINQ II insertable cardiac monitor has received FDA clearance and a CE mark in Europe for treatment of patients with abnormal heart rhythms who experience infrequent symptoms, such as dizziness, palpitations, fainting and chest pain.

The wireless device is about one-third the size of a AAA battery and can be remotely programmed by clinicians without the need for patient visits.

Patients can either send data collected by the device using a smartphone app or a home communicator device.